Price Alert

Health Sciences Acquisiti... (HSAQ)

NASDAQ: HSAQ · Real-Time Price · USD

13.31

2.59 (24.16%)

At close: Jan 26, 2023, 9:59 PM

Health Sciences Acquisitions 2 Statistics

Share Statistics

Health Sciences Acquisitions 2 has n/a shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	49
FTD / Avg. Volume	0.07%

Short Selling Information

The latest short interest is 256.92K, so 0% of the outstanding shares have been sold short.

Short Interest	256.92K
Short % of Shares Out	n/a
Short % of Float	4.06%
Short Ratio (days to cover)	2.02

Valuation Ratios

The PE ratio is -8031.07 and the forward PE ratio is null. Health Sciences Acquisitions 2's PEG ratio is 0.

PE Ratio	-8031.07
Forward PE	n/a
PS Ratio	185780.16
Forward PS	n/a
PB Ratio	14870.08
P/FCF Ratio	-9638.49
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Health Sciences Acquisitions 2.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.07.

Current Ratio	4.27
Quick Ratio	4.26
Debt / Equity	0.07
Debt / EBITDA	-0.03
Debt / FCF	-0.04
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	undefined
Asset Turnover	0.03
Inventory Turnover	1.18

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0, so Health Sciences Acquisitions 2's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	10.07
200-Day Moving Average	9.96
Relative Strength Index (RSI)	96.86
Average Volume (20 Days)	71,375

Income Statement

In the last 12 months, Health Sciences Acquisitions 2 had revenue of 2.64M and earned -61.02M in profits. Earnings per share was -1.66.

Revenue	2.64M
Gross Profit	2.43M
Operating Income	-64.3M
Net Income	-61.02M
EBITDA	-64.3M
EBIT	n/a
Earnings Per Share (EPS)	-1.66

Full Income Statement

Balance Sheet

The company has 22.26M in cash and 2.24M in debt, giving a net cash position of 20.02M.

Cash & Cash Equivalents	22.26M
Total Debt	2.24M
Net Cash	20.02M
Retained Earnings	-309.88M
Total Assets	59.05M
Working Capital	36.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -50.56M and capital expenditures -289K, giving a free cash flow of -50.85M.

Operating Cash Flow	-50.56M
Capital Expenditures	-289K
Free Cash Flow	-50.85M
FCF Per Share	0

Full Cash Flow Statement

Margins

Gross margin is 92.27%, with operating and profit margins of -2437.49% and -2313.27%.

Gross Margin	92.27%
Operating Margin	-2437.49%
Pretax Margin	-2313.27%
Profit Margin	-2313.27%
EBITDA Margin	-2437.49%
EBIT Margin	-2437.49%
FCF Margin	-1927.48%

Dividends & Yields

HSAQ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for HSAQ.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-9.33
Piotroski F-Score	3